| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69f03c1bdf9b9f2bd7b0350463c2ada7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95eeb3180f94415d618c91bd614e1513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fefaa6ef129501e3c08078291b0fb0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb7d2654e7c11abfd6aad0e206f33b0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f431c67c68e613066df1ed2cf01ff83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c108b51ea7c220697e3f79c1ced08231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a2553c6b1fab1376af748c8b46e64d6 |
| publicationDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2450998-T3 |
| titleOfInvention |
New variants of rubella E1 envelope protein and its use in the detection of anti-rubella antibodies |
| abstract |
Rubella E1 antigen comprising amino acids 201 to 432, provided that said antigen does not have the sequences corresponding to amino acids 143 to 164 and 454 to 481 of native rubella E1 antigen and that it contains two disulfide bridges, in which a disulfide bridge is formed between Cys225 and Cys235 (C13-C14) and a second disulfide bridge is formed between Cys349 and Cys352 (C17-C18). |
| priorityDate |
2007-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |